Similarly, tumor growth inhibition rate in mice immunized with pVAX1-PSCA-F2A-CTLA-4 was significantly higher than that in mice immunized with pVAX1-PSCA (P<0.05; Figure 4C). Here, CTLA4 is linked to neoplasm.